Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Auron Therapeutics, Inc. logo — Targeting cell state to deliver next-generation targeted can...

Auron Therapeutics, Inc.

Targeting cell state to deliver next-generation targeted cancer therapies

Founded 2018 United States Newton, United States 24 employees Series A Total: $61.41M Biotechnology, Health Care +1

General Information

Company Name Auron Therapeutics, Inc.
Founded Year 2018
Location United States Newton, United States
Employees 24
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Auron Therapeutics, Inc.. To contact Auron Therapeutics, Inc., visit aurontx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Auron Therapeutics, Inc. compare?

A PDF of Auron Therapeutics, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Auron Therapeutics, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Auron Therapeutics, Inc.

Auron Therapeutics, founded in 2018, is a privately held patient-centered, platform-powered, product-driven oncology company. The company's slogan, "Targeting cell state to deliver next-generation targeted cancer therapies," embodies its focus on identifying and targeting cell state to treat a range of solid tumors and hematological malignancies. Operating in the Biotechnology, Health Care, and Health and Wellness industries, Auron Therapeutics is headquartered in the United States. A significant milestone for the company was the $48.00M Series A investment received on 20 July 2022. The investment was led by notable venture capital firms and organizations including Apollo Health Ventures, Casdin Capital, Polaris Partners, Qiming Venture Partners USA, Eli Lilly, Franklin Berger, DCVC Bio, Arkin Bio Ventures, Mubadala Capital Ventures, and BrightEdge Fund. This significant investment is a testament to Auron Therapeutics' potential and the confidence of renowned investors in the company's vision and approach.

Business keywords: oncology, cancer therapy, cell state targeting, solid tumors, hematological malignancies, differentiation therapy, endogenous cellular programs, omic datasets, flow cytometry, precision medicine, drug development, patient-centered approach

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $48.00M 10
Apollo Health Ventures Casdin Capital Polaris Partners
Apollo Health Ventures, Casdin Capital +8
20 Jul 2022
Seed Round $12.75M -
28 Jan 2021
Debt Financing $660.00K -
24 Jul 2018

Auron Therapeutics, Inc. Alternatives & Competitors

View All Alternatives
Auron Therapeutics, Inc. vs
ProfoundBio
ProfoundBio United States

An oncology biotherapeutics company

Series B
8 employees
Biotechnology, Health and Wellness
Auron Therapeutics, Inc. vs
ONK Therapeutics
ONK Therapeutics Ireland

Pioneering optimally engineered NK cell therapies to cure patients with cancer.

Series A
20 employees
Biotechnology, Health Care
Auron Therapeutics, Inc. vs
Prescient Therapeutics
Prescient Therapeutics Australia

A clinical stage oncology company developing personalised medicine approaches to cancer; cellular &...

Post-IPO Equity
14 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Auron Therapeutics, Inc.

Targeting cell state to deliver next-generation targeted cancer therapies
Auron Therapeutics, Inc. was founded in 2018.
Auron Therapeutics, Inc. is headquartered in Newton, United States.
Auron Therapeutics, Inc. operates in Biotechnology, Health Care and Health and Wellness. Its work centres on oncology, cancer therapy, cell state targeting and solid tumors.
Auron Therapeutics, Inc. has approximately 24 employees.
Auron Therapeutics, Inc. has completed 3 funding rounds, raising a total of $61.41M. The latest funding stage is Series A.
Top alternatives and competitors to Auron Therapeutics, Inc. include ProfoundBio, ONK Therapeutics, Prescient Therapeutics, GammaDelta Therapeutics, Kiromic Biopharma, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Auron Therapeutics, Inc. and ProfoundBio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Auron Therapeutics, Inc., https://bouncewatch.com/company/auron-therapeutics, updated 25 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout